Cassidy Cunningham, DO

Residency: Emory University School of Medicine
Medical school: University of New England College of Osteopathic Medicine

CCA - TICH-NOAC.jpg
In this underpowered RCT, no evidence was found that TXA limits HE nor that it improves clinical outcomes by 90 days in NOAC-associated ICH. That being said, there were no major safety concerns noted
CCA - PATCH-trauma.jpg
The PATCH-Trauma Trial confirms short-term benefits of tranexamic acid (TXA) for prehospital treatment of the bleeding trauma patient, despite no evidence of long-term functional benefits.
CHAT NOW
CHAT OFFLINE